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Abstract
Ewen Speed and Russell Mannion correctly identify several contours of the challenges for health policy in what 
it is useful to think of as a post-democratic era. I argue that the problem for public health is not populism per 
se, but rather the distinctive populism of the right coupled with the failure of the left to develop compelling 
counternarratives. Further, defences of ‘science’ must be tempered by recognition of the unavoidably political 
dimensions of the (mis)use of scientific findings in public policy. 
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Ewen Speed and Russell Mannion1 correctly and eloquently identify several contours of the challenges for health policy in what it is useful to think of as a 
post-democratic era. Citing the crucial work of Inglehart 
and Norris,2 they perform the indispensable service of 
foregrounding for health researchers and practitioners a 
process that blind-sided many of us (myself included), even 
though Zakaria warned two decades ago about the rise of 
‘illiberal democracy’3; Freedom House identified the year 
2006 as a turning point4; and Diamond – one of the founding 
editors of Journal of Democracy, which these days is well 
worth reading – explicated multiple manifestations of the 
trend in 2015.5
Populism is a complicated if not Protean category. I would 
argue that the problem for health policy is not populism per 
se but rather, in many political contexts, the ability of key 
protagonists in the transnational capitalist class6-9 and allied 
domestic elites to misdirect[1] the identification of threats to the 
health and well-being of populations left behind by neoliberal 
economic integration. Predictably in view of the financial 
interests of the key backers of Brexit and (more visibly) 
the Trump campaign, neither targeted fraudster bankers, 
billionaire hedge fund investors in private equity, or the 
acolytes of ‘shareholder value’10,11 whose activities especially 
in the United States drove the destruction of industrial jobs. 
Unfortunately, these protagonists were also largely ignored 
by the mainstream political left. In the UK context, the most 
conspicuous issue is the Labour Party’s catastrophic failure 
to challenge the Conservative ascription of the post-2008 
financial crisis and recession to Labour’s economic policies, 
rather than to politically protected corporate crime on the 
other side of the Atlantic. In the United States, absent a 
competing and credible narrative that challenged the role 
of corporate capital in spreading economic insecurity and 
inequality[2],12 the remarkable turn to Trump among the left-
behind – those whose health status is most clearly endangered 
by ‘neoliberal epidemics,’13 as The Economist pointed out after 
the election14 – is lamentable but hardly surprising. 
We can and should envision an alternative populism, organised 
around a rubric like: ‘Stop, you’re killing us!’ This is not 
original; it is adapted from the slogan of the ‘Trainites’: cells 
of environmental activists inspired, although not organised, 
by an environmental scientist named Austin Train in John 
Brunner’s dystopian 1972 novel The Sheep Look Up.15 Brunner 
anticipated a near-future of ecological collapse, against 
the background of a bellicose and domestically callous US 
government led by a buffoonish president (‘Prexy’) who bears 
an uncanny resemblance to one Donald Trump. Sometimes, 
the fictional past is factual prologue. This form of populism 
has emerged in some media coverage (Figure) of a recent 
finding that as the number of frail older people receiving 
social care from local governments in the United Kingdom 
fell by 300 000 post-2010,16 the number of deaths in England 
and Wales increased by 39 074 in the year ending July, 2015 
over the preceding year, with 32 208 of those deaths occurring 
among those aged 80 and older.17 The straightforward insight 
conveyed by the headline in the figure remains, for the 
moment, outside the political mainstream – a point of special 
concern in the election campaign that at this writing is under 
way in the United Kingdom. Researchers and practitioners 
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who care about health inequalities and their economic and 
political substrates should welcome this form of populism; 
ally ourselves with those who can communicate the message 
to a broader audience; and do the best we can to ensure the 
intellectual integrity both of the relevant findings and of the 
way they are used in public policy and political advocacy. 
That said, the politics of science and evidence in a ‘post-
truth world’ are unavoidably complicated. The tactic of 
‘manufacturing uncertainty’ has a long and ignoble history, 
perfected by the tobacco industry and also deployed in 
defence of various environmental, workplace and consumer 
product contaminants,18-20 conspicuously in recent efforts 
to resist European Union (EU) regulation of endocrine-
disrupting chemicals.21 When Trump administration 
officials deny causal connections between human activity 
and climate change, in the face of findings from the largest-
ever multinational scientific collaboration,22 it is tempting 
simply to defend ‘science.’ Efforts to undermine the integrity 
of scientific investigation or to restrict scientific researchers’ 
public disclosure of their findings, as under the Canadian 
government of Conservative Stephen Harper, must always 
be resisted. At the same time, we must recognise that the 
production of scientific knowledge is a social process, and 
that there is a political dimension to how public policy deals 
with scientific uncertainty or indeterminacy. 
More explicit reflection on this latter point is especially 
valuable. For example, the demand for epidemiological 
evidence of health effects from environmental risks can be 
cloaked in the rhetoric of good science, and industrial firms 
and their front organisations have often used this tactic – a 
variant of manufacturing uncertainty – to resist regulation. 
A more accurate description, as environmental economist 
Talbot Page pointed out long ago, is of an approach that 
‘requires positive evidence of “dead bodies” before acting.’23 
The approach neglects such issues as the difficulties associated 
with demonstrating statistical significance at the conventional 
(but entirely arbitrary) 95% confidence level, because of 
statistical power limitations driven by sample sizes and effect 
sizes. Choices about what represents a ‘conservative’ approach 
to scientific evidence in such situations, as for example in 
the broader context of the effects of austerity on health, are 
inescapably value-driven and political.24
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Endnotes
[1] Misdirection is a term drawn from stage magic, in which the performer 
directs the audience’s attention elsewhere whilst the necessary sleight-of-hand 
is carried out.  Its relevance in the current context is obvious.
[2] In 1993, for example, investment banker Steven Rattner defended massive 
industrial job losses, and pay cuts in those that remained, as the necessary 
price of moving to a high-productivity economy, noting that such an economy 
brings ‘the promise of higher incomes for more efficient workers and fewer jobs 
for everyone else.’
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